# US 2020/0370058 A1 · A htp genomic engineering platform for improving escherichia coli

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0370058 A1
- Document ID: US20200370058A1
- Status: Published application
- Kind: A1
- Application number: 16/620,069
- Filed: 2018-06-06
- Published: 2020-11-26
- Earliest claimed: 2017-06-06
- Assignees: Zymergen Inc.
- Applicants: Zymergen Inc.
- Inventors: Matthew Davis; Christy Wisnewski; Patrick Westfall; Zach Serber; Erik Jedediah Dean; Shawn Manchester; Katherine Gora; Erin Shellman; Aaron Kimball; Shawn Szyjka; Barbara Frewen; Thomas Treynor; Michael Flashman; Robert Haushalter; Stacy-Anne Morgan; Michael Blaisse; Prabha Ramakrishnan; Kyle Rothschild-Mancinelli; Youngnyun Kim
- Web page: https://patentgrep.com/patent/US20200370058A1

## CPC

- C12N 15/1058: {Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms}
- C12N 15/73: Expression systems using phage (lambda) regulatory sequences
- C12N 15/1079: {Screening libraries by altering the phenotype or phenotypic trait of the host (reporter assays C12N15/1086)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present disclosure provides a HTP genomic engineering platform for improving Escherichia coli. that is computationally driven and integrates molecular biology, automation, and advanced machine learning protocols. This integrative platform utilizes a suite of HTP molecular tool sets to create HTP genetic design libraries, which are derived from, inter alia, scientific insight and iterative pattern recognition.

## Claims

### Claim at position 1

-88. (canceled)

### Claim 89

A chimeric synthetic promoter operably linked to a heterologous gene for expression in a microbial host cell, wherein the chimeric synthetic promoter is 60-90 nucleotides in length and consists of a distal portion of lambda phage pR promoter, variable −35 and −10 regions of lambda phage pL and pR promoters that are each six nucleotides in length, core portions of lambda phage pL and pR promoters and a 5′ UTR/Ribosomal Binding Site (RBS) portion of lambda phage pR promoter.

### Claim 90 (depends on 89)

The chimeric synthetic promoter of claim 89, wherein nucleic acid sequences of the distal portion of the lambda phage pR promoter, the variable −35 and −10 regions of the lambda phage pL and pR promoters, the core portions of the lambda phage pL and pR promoters and the 5′ UTR/Ribosomal Binding Site (RBS) portion of the lambda phage pR promoter are selected from the nucleic acid sequences found in Table 1.5.

### Claim 91

A chimeric synthetic promoter operably linked to a heterologous gene for expression in a microbial host cell, wherein the chimeric synthetic promoter is 60-90 nucleotides in length and consists of a distal portion of lambda phage pR promoter, variable −35 and −10 regions of lambda phage pL and pR promoters that are each six nucleotides in length, core portions of lambda phage pL and pR promoters and a 5′ UTR/Ribosomal Binding Site (RBS) portion of the promoter of the E. coli acs gene.

### Claim 92 (depends on 91)

The chimeric synthetic promoter of claim 91, wherein nucleic acid sequences of the distal portion of the lambda phage pR promoter, the variable −35 and −10 regions of the lambda phage pL and pR promoters, the core portions of the lambda phage pL and pR promoters and the 5′ UTR/Ribosomal Binding Site (RBS) portion of the promoter of the E. coli acs gene are selected from the nucleic acid sequences found in Table 1.5.

### Claim 93 (depends on 89)

The chimeric synthetic promoter of claim 89, wherein the chimeric synthetic promoter consists of a nucleic acid sequence selected from SEQ ID NOs. 132-152, 159-160, 162, 165, 174-175, 188, 190, 199-201 or 207.

### Claim 94 (depends on 91)

The chimeric synthetic promoter of claim 91, wherein the chimeric synthetic promoter consists of a nucleic acid sequence selected from SEQ ID NOs. 153-158, 161, 163-164, 166-173, 176-187, 189, 191-198 or 202-206.

### Claim 95 (depends on 89)

The chimeric synthetic promoter of claim 89, wherein the microbial host cell is E. coli.

### Claim 96 (depends on 95)

The chimeric synthetic promoter of claim 95, wherein the heterologous gene encodes a protein product of interest found in Table 2.

### Claim 97 (depends on 95)

The chimeric synthetic promoter of claim 95, wherein the heterologous gene is a gene that is part of a lysine biosynthetic pathway.

### Claim 98 (depends on 97)

The chimeric synthetic promoter of claim 97, wherein the heterologous gene is selected from the asd gene, the ask gene, the hom gene, the dapA gene, the dapB gene, the dapD gene, the ddh gene, the argD gene, the dapE gene, the dapF gene, the lysA gene, the lysE gene, the zwf gene, the pgi gene, the ktk gene, the fbp gene, the ppc gene, the pck gene, the ddx gene, the pyc gene or the icd gene.

### Claim at position 12

-110. (canceled)

### Claim 111 (depends on 91)

The chimeric synthetic promoter of claim 91, wherein the microbial host cell is E. coli.

### Claim 112 (depends on 111)

The chimeric synthetic promoter of claim 111, wherein the heterologous gene encodes a protein product of interest found in Table 2.

### Claim 113 (depends on 111)

The chimeric synthetic promoter of claim 111, wherein the heterologous gene is a gene that is part of a lysine biosynthetic pathway.

### Claim 114 (depends on 113)

The chimeric synthetic promoter of claim 113, wherein the heterologous gene is selected from the asd gene, the ask gene, the hom gene, the dapA gene, the dapB gene, the dapD gene, the ddh gene, the argD gene, the dapE gene, the dapF gene, the lysA gene, the lysE gene, the zwf gene, the pgi gene, the ktk gene, the fbp gene, the ppc gene, the pck gene, the ddx gene, the pyc gene or the icd gene.
